On January 24, the State Food and Drug Administration deployed in-depth special rectification actions for drug safety at the 2022 National Drug Supervision and Administration and Party Style and Clean Government Construction Work Conference. The meeting emphasized that it is necessary to conscientiously implement the spirit of General Secretary Xi Jinping's important instructions and the decision-making and deployment of the Party Central Committee, strengthen the "four awareness", strengthen the "four self-confidence", and achieve "two maintenance", adhere to the people's health as the center, and conscientiously implement "Four strictest" requirements, strictly prevent and strictly control drug safety risks, and effectively ensure the safety and effectiveness of the people's medication, and take practical actions to welcome the victory of the Party's 20th National Congress.
The meeting pointed out that the safety responsibility of drugs (including medical devices and cosmetics, the same below) is a major responsibility, which is related to the safety of people's lives. It is necessary to increase the investigation of potential risks. Potential security risks, the fastest and maximum risk control. It is necessary to implement the main tone of "strictness" in all aspects, increase the supervision of drug research and development, registration, production, operation, and use, and focus on strengthening the rectification of hidden dangers of drugs in urban and rural areas, rural areas and online sales, and effectively solve the problems around the masses. drug safety issues. It is necessary to adhere to the rule of law and chaos, to strengthen the connection between execution and discipline, to consolidate the supervision responsibility and the main responsibility of the enterprise, to rectify the order of the drug market, severely punish violations of laws and regulations, and comprehensively strengthen the supervision of the whole product life cycle.
The meeting called for a deep understanding of the harmfulness of drug-related illegal and criminal acts, and to organize special drug safety rectification actions across the country. Adhere to treating both the symptoms and root causes, highlighting the problem orientation and effect orientation, purifying the market environment through precise policy implementation, and strictly investigating and punishing violations of the law. Irregularities. Unremittingly strengthen the supervision of key products such as vaccines, blood products, special drugs, implantable medical devices, and children's cosmetics, focus on strengthening the quality supervision of Chinese herbal medicines, and continue to do a good job in the new coronavirus vaccine and therapeutic drugs, testing reagents, medical protective clothing, medical Quality supervision of masks, etc., organize special inspections and special spot checks to ensure the quality and safety of medical equipment for epidemic prevention and control. It is necessary to firmly establish bottom-line thinking, strengthen the awareness of urgency, strengthen the supervision of online sales of drugs, medical devices, and cosmetics, and focus on strengthening supervision on online sales of prescription drugs and the implementation of responsibilities on third-party platforms. Make good use of the online sales monitoring platform, severely crack down on illegal online sales of drugs, medical devices, and cosmetics, further increase law enforcement and case handling, and focus on severely punishing a number of violations of laws and regulations, forming a strong deterrent. It is necessary to strengthen coordination with public security, market supervision and other departments, improve the connection system and mechanism between drug administrative law enforcement and criminal justice, smooth the channels for joint crackdown on drug violations and crimes, form a strong law enforcement force, and always maintain a high pressure on drug safety violations and crimes. Crack down on all kinds of illegal and criminal activities, and resolutely build a strong line of defense for drug safety.